Voglibose

Indications	Oral Diabetes mellitus *Adult:* 200-300 mcg tid. *Elderly:* Initiate at lower doses.
Contraindications	Inflammatory bowel disease; GI obstruction or patients predisposed to it; conditions which may deteriorate as a result of increased gas formation eg, hernia; severe ketosis; diabetic coma or pre-coma; severe infection; hypersensitivity; pregnancy; lactation. Not to be used as monotherapy in IDDM.
Warnings / Precautions	History of laparotomy or ileus. Roemheld's syndrome, stenosis, severe hepatic or renal impairment. Child <18 yr; elderly. Monitor LFT. Treat hypoglycaemic episodes with glucose (not with sucrose).
Adverse Reactions	Flatulence; abdominal distension; diarrhoea; pain; skin reactions; hypoglycemia; increased LFT. Potentially Fatal: Hepatotoxicity.
Drug Interactions	May enhance effects of other antidiabetics including insulin. See Below for More voglibose Drug Interactions
Mechanism of Actions	Voligbose has general properties similar to acarbose and selectively inhibits α-glucosidase in the enteric canal, delaying the digestion and absorption of carbohydrate, thereby suppressing sharp increase in post-prandial plasma glucose.
Administration	Should be taken with food. (Take just before meals.)
Storage Conditions	Oral: Store below 30°C.
ATC Classification	A10BF03 - voglibose ; Belongs to the class of alpha glucosidase inhibitors. Used in the treatment of diabetes.
Storage	Oral: Store below 30°C.
Available As	Voglibose 0.2 mg Voglibose 0.3 mg

Subscribe to our e-mail newsletter to receive updates.

Voglibose Containing Brands

We are Developing Our database, More results coming soon.

Voglibose is used in following diseases

We are Developing Our database, More results coming soon.

Drug - Drug Interactions of Voglibose

We are Developing Our database, More results coming soon.